retatrutide safety trial results Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Lilly's triple agonist achieves 16.8%

If dissolution takes significantly longer or appears incomplete, this may indicate compromised product quality or improper storage before reconstitution

While incretin-based therapies have been commercially available since 2005, most clinical trials only report short term outcomes

doi: 10.1210/jc.2003-031403 18 HanF.HouN.LiuY.HuangN.PanR.ZhangX.et al

Top choices: Greek yogurt (20g), 2 hard-boiled eggs (12g), cottage cheese (14g per 1/2 cup), deli turkey roll-ups (15g), string cheese with almonds (12g), protein bars (15-20g), and edamame (17g per cup)

Athletes can track their HRV with ithlete with an exclusive extended free trial for Training Peaks users